Immunome Inc’s recent filing unveils that its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $46900.0 on Jun 03 ’25. In the deal valued at $9.38 per share,5,000 shares were bought. As a result of this transaction, BIENAIME JEAN JACQUES now holds 36,415 shares worth roughly $0.34 million.
Then, BIENAIME JEAN JACQUES bought 7,800 shares, generating $60,684 in total proceeds. Upon buying the shares at $7.78, the Director now owns 31,415 shares.
Before that, SIEGALL CLAY B bought 137,100 shares. Immunome Inc shares valued at $999,459 were divested by the President and CEO at a price of $7.29 per share. As a result of the transaction, SIEGALL CLAY B now holds 806,736 shares, worth roughly $7.42 million.
Lake Street initiated its Immunome Inc [IMNM] rating to a Buy in a research note published on April 02, 2025; the price target was $23. A number of analysts have revised their coverage, including Stephens’s analysts, who began to cover the stock in early November with a ‘”an Overweight”‘ rating. Piper Sandler began covering IMNM with “an Overweight” recommendation on May 31, 2024. JP Morgan started covering the stock on April 30, 2024. It rated IMNM as “an Overweight”.
Price Performance Review of IMNM
On Friday, Immunome Inc [NASDAQ:IMNM] saw its stock fall -6.03% to $9.20. Over the last five days, the stock has gained 0.77%. Immunome Inc shares have fallen nearly -13.37% since the year began. Nevertheless, the stocks have fallen -41.40% over the past one year. While a 52-week high of $16.81 was reached on 02/10/25, a 52-week low of $5.15 was recorded on 04/09/25.
Levels Of Support And Resistance For IMNM Stock
The 24-hour chart illustrates a support level at 8.86, which if violated will result in even more drops to 8.51. On the upside, there is a resistance level at 9.71. A further resistance level may holdings at 10.21.
How much short interest is there in Immunome Inc?
A steep rise in short interest was recorded in Immunome Inc stocks on 2025-05-30, dropping by -0.41 million shares to a total of 13.24 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-30 was 13.65 million shares. There was a decline of -3.07%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on April 15, 2024 when Guggenheim began covering the stock and recommended ‘”a Buy”‘ rating along with a $35 price target.
